Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
10.32
-0.03 (-0.29%)
Oct 16, 2025, 2:22 PM EDT - Market open
Nurix Therapeutics Employees
Nurix Therapeutics had 286 employees as of November 30, 2024. The number of employees increased by 2 or 0.70% compared to the previous year.
Employees
286
Change (1Y)
2
Growth (1Y)
0.70%
Revenue / Employee
$292,612
Profits / Employee
-$855,892
Market Cap
793.44M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 286 | 2 | 0.70% |
Nov 30, 2023 | 284 | -13 | -4.38% |
Nov 30, 2022 | 297 | 55 | 22.73% |
Nov 30, 2021 | 242 | 107 | 79.26% |
Nov 30, 2020 | 135 | 42 | 45.16% |
Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NRIX News
- 5 days ago - Nurix: Bexobrutideg Advancement Presses Forward With H2 2025 Milestones - Seeking Alpha
- 6 days ago - Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 4 weeks ago - Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis - GlobeNewsWire
- 4 weeks ago - Nurix Therapeutics, Inc. (NRIX) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript) - Seeking Alpha
- 4 weeks ago - Nurix Therapeutics, Inc. (NRIX) Presents At Baird Global Healthcare Conference 2025 (Transcript) - Seeking Alpha
- 5 weeks ago - Nurix Therapeutics, Inc. (NRIX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript - Seeking Alpha
- 5 weeks ago - Nurix Therapeutics, Inc. (NRIX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Nurix Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire